Advertisement

Topics

Nonproliferative retinopathy - Biotech, Pharma and Life Science Channel

01:18 EDT 26th June 2017 | BioPortfolio

PubMed Articles [405 Associated PubMed Articles listed on BioPortfolio]

Clinical and molecular cytogenetic characterization of four unrelated patients carrying 2p14 microdeletions.

We report the clinical and molecular cytogenetic characterization of four unrelated patients from France and Spain, carrying 2p14 microdeletions and presenting with intellectual disability and dysmorp...

Pediatric Retinal Detachment.

The number of retinal detachments in children is rarely compared to the number of retinal detachments in adults; only 3 - 7% occur in children. The main predisposing factors are trauma, myopia, he...

Obstructive Sleep Apnoea and Retinopathy in Patients with Type 2 Diabetes: A Longitudinal Study.

To assess the relationship between obstructive sleep apnoea (OSA) and diabetic retinopathy (DR) in patients with type 2 diabetes (T2D) and to assess whether OSA is associated with its progression).

Angiogenesis in metabolic-vascular disease.

Angiogenesis, literally formation of new blood vessels, is the main process through which the vascular system expands during embryonic and postnatal development. Endothelial cells, which constitute th...

HEMORRHAGIC VASCULITIS AND RETINOPATHY HERALDING AS AN EARLY SIGN OF BACTERIAL ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION.

To describe a case series of postintravitreal injection, bacterial endophthalmitis heralded by hemorrhagic retinal vasculitis.

Diagnosis of tuberous sclerosis complex in a patient referred for uncontrolled hypertension and renal dysfunction: a case highlighting the importance of proper diagnostic work-up of hypertensive patients.

: We report a case of a 39-year-old woman with resistant hypertension and renal dysfunction. The patient was hospitalized 3 months earlier for dyspnea at the Department of Cardiology, where she was di...

OCT Angiography and Visible-Light OCT in Diabetic Retinopathy.

In recent years, advances in optical coherence tomography (OCT) techniques have increased our understanding of diabetic retinopathy, an important microvascular complication of diabetes. OCT angiograph...

VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases.

Müller glia (MG) are major retinal supporting cells that participate in retinal metabolism, function, maintenance, and protection. During the pathogenesis of diabetic retinopathy (DR), a neurovascula...

Content Design and System Implementation of a Teleophthalmology System for Eye Disease Diagnosis and Treatment and Its Preliminary Practice in Guangdong, China.

We have developed a new telemedicine system for comprehensive eye examination, diabetic retinopathy (DR) screening, and eye disease diagnosis and treatment. The novel points of the system include a ta...

Dietary Intake of Omega-3 Fatty Acids From Fish and Risk of Diabetic Retinopathy.

News Articles [171 Associated News Articles listed on BioPortfolio]

Central Serous Retinopathy Requires Individualized Approach

Most cases of CRS resolve spontaneously, but chronic CRS can cause vision loss and should be treated. Unfortunately, there is no standard treatment, and most are not reimbursed. Medscape Medical New...

Diabetic retinopathy Epidemiology Forecast To 2023 [Updated: 31052017] Prices from USD $2338

DelveInsight Diabetic retinopathy Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Diabetic retinopathy in seven major markets US, France, Germany, Italy, Spain, UK an...

Strategies to encourage more patients to undergo eye tests

PHILADELPHIA — Education, along with a screening reminder card, may encourage more patients to get diabetic retinopathy eye screening exams, according to a presenter here at the annual meeting of th...

DelveInsight Reports - June 2017 Discount - Immunotherapy to Cutaneous Squamous cell Carcinoma

Delve Insight June 2017 Discount Offer - JUNE 2017 DelveInsight is a leading Business Consulting and Market Research Firm. DelveInsight combine industry expertise with probing market insights in...

Diabetic Retinopathy Epidemiology Forecast To 2023 [Updated: 30052017] Prices from USD $2338

DelveInsight's Diabetic Retinopathy Epidemiology Forecast to 2023 Report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven major markets US, France, Germany, Italy, Spa...

UWF-FA identifies retinopathy earlier than UWF photography alone

In eyes with less severe diabetic retinopathy, ultra-widefield fluorescein angiography identifies the more severe form earlier and allows for identification of nonproliferation not readily evident on ...

Diabetic Retinopathy Market Insights, Epidemiology and Market Forecast2023 [Updated: 30052017] Prices from USD $4208

DelveInsight's Diabetic Retinopathy Market Insights, Epidemiology and Market Forecast2023 Report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven major markets US, Fra...

Regeneron and Bayer Report Positive One-Year Results from Two Phase 3 Trials of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema

TARRYTOWN, N.Y., Aug. 6, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA® (afl...

Ohr Pharmaceutical Announces Addition of Dr. John Wroblewski to Ophthalmic Scientific Advisory Board

NEW YORK, Aug. 7, 2013 /PRNewswire/ -- Ohr Pharmaceutical Inc. (NasdaqCM: OHRP) today announced the addition of John J. Wroblewski M.D. to its Scientific Advisory Board ("SAB"). The board, comprised o...

Diabetic Gastroparesis Forecast in 12 Major Markets 20172027 [Updated: 01042017] Prices from USD $6100

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Diabetic Gastroparesis in 12 Major MarketsGastroparesis is a syndrome characterised by delayed gastric emptying in the absence of mec...

Events [0 Results]

None

Companies [7 Associated Companies listed on BioPortfolio]

Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB‐9778, is ...

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to de...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen def...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Clinical Trials [264 Associated Clinical Trials listed on BioPortfolio]

The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

The purpose of this study is to evaluate the safety and efficacy of subcutaneously administered AKB-9778 15mg once daily or 15mg twice daily for 12 months in patients with moderate to seve...

Effectiveness of Pharmacotherapy Follow-up Care in Outpatients With Type 2 Diabetes Mellitus

Hypothesis: Pharmacotherapy follow-up can improve clinical outcomes of outpatients with type 2 diabetes mellitus. Methods: In this single blind, placebo-controlled trial, the participants...

Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy

Diabetes Mellitus is the most common disorder seen. The impact of this disease on the quality of life, and on morbidity and mortality through the complications that affect the small and la...

Effect of E Balance Pro Therapy on Diabetes and Related Complications

This is an observational study, to test the hypothesis that E Balance Pro Therapy micro-current treatments, delivered with precision in amplitude, waveform and pulsing pattern, adapted by ...

Diabetic Retinopathy Assessed by Ultra-wide

Patients with diabetic macular edema treated with aflibercept injections for visual impairment will be observed in standard care during 12 months. They will undergo visual assessments by U...

VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

The Retinopathy of Prematurity (ROP) is one of the leading causes of blindness on the pediatric age worldwide. This pathology is characterized for arrest of the normal vascular and neurona...

Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab

To determine the serum concentrations of ranibizumab and vascular endothelial growth factor (VEGF) in infants with retinopathy of prematurity (ROP) who received intravitreal ranibizumab

The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)

Background Diabetic eye disease is the most frequent complication among the 320,000 Danes with diabetes. The formation of new vessels (PDR) in the inner part of the eye (retina) is a feare...

Metabolomics in Surgical Ophthalmological Patients

Metabolomics consists in the study of metabolites in body fluids or tissues. It investigates the consequences of the activity of genes and proteins. One of its advantages is that it is abl...

PROTECT2 - See Official Title for Response to PRS Review Comments [1]

The PROTECT2 pilot study is a single cohort prospective study to gather pilot data and finalize operational details of the main study. The PROTECT2 main study is a prospective randomized ...

Videos

None available.

Medical and Biotech [MESH] Definitions

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Degenerative changes to the RETINA due to HYPERTENSION.

A drug used to reduce hemorrhage in diabetic retinopathy.

Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Quick Search
Advertisement
 
review and buy Nonproliferative retinopathy market research data and corporate reports here

Channels Quicklinks